Press Release Distribution Services

Global Pegvisomant Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. According to this study, over the next five years the Pegvisomant Drugs market will register a xx% CAGR in terms of revenue, the global market size will... more

Global Somavert Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. According to this study, over the next five years the Somavert market will register a xx% CAGR in terms of revenue, the global market size will reach... more

Global Pegvisomant Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. According to this study, over the next five years the Pegvisomant market will register a xx% CAGR in terms of revenue, the global market size will reach... more

Global Somatuline Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome According to this study, over the next five years the Somatuline Drugs market will register a xx% CAGR in terms of revenue,... more

Global Lanreotide Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome According to this study, over the next five years the Lanreotide Drugs market will register a xx% CAGR in terms... more

Global Signifor Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Signifor is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Signifor Drugs market will register a... more

Global Pasireotide Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Pasireotide Drugs market will register... more

Global Sandostatin LAR Drugs Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. According to this study, over the next... more

Global Somatuline Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome According to this study, over the next five years the Somatuline market will register a xx% CAGR in terms of revenue,... more

Global Lanreotide Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome According to this study, over the next five years the Lanreotide market will register a xx% CAGR in terms of revenue,... more

Global Signifor Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Signifor is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Signifor market will register a xx% CAGR... more

Global Pasireotide Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. According to this study, over the next five years the Pasireotide market will register a... more

Global Sandostatin LAR Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. According to this study, over the next... more

Global Acral Lentiginous Melanoma Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. According to this study, over the next five years the Acral Lentiginous... more

Global Acral Lentiginous Melanoma Treatment Market Growth 2018-2023

(EMAILWIRE.COM, November 19, 2018 ) Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. According to this study, over the next five years the Acral Lentiginous... more